Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $45.51 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intercept Pharmaceuticals, Inc. | $23.41 | 1 | $0 (2024) |
| AbbVie Inc. | $22.10 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.41 | 1 | Intercept Pharmaceuticals, Inc. ($23.41) |
| 2021 | $22.10 | 1 | AbbVie Inc. ($22.10) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/24/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/05/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 671 | 797 | $991,070 | $65,111 |
| 2022 | 14 | 622 | 715 | $948,162 | $51,225 |
| 2021 | 17 | 757 | 901 | $1.1M | $63,527 |
| 2020 | 15 | 635 | 774 | $709,564 | $48,304 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 217 | $80,290 | $12,445 | 15.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 85 | 86 | $299,280 | $9,709 | 3.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 97 | 101 | $59,590 | $9,479 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $54,000 | $8,615 | 16.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 30 | 30 | $130,500 | $5,810 | 4.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 67 | $32,830 | $5,578 | 17.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 23 | 23 | $67,390 | $3,562 | 5.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $49,810 | $2,764 | 5.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $103,350 | $2,682 | 2.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $62,200 | $2,555 | 4.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 20 | $45,200 | $1,481 | 3.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 100 | 102 | $6,630 | $430.58 | 6.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 90 | 90 | $301,500 | $9,564 | 3.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 41 | 41 | $171,380 | $7,026 | 4.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 89 | 181 | $41,630 | $5,072 | 12.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $25,300 | $4,651 | 18.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $25,050 | $4,458 | 17.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 53 | 53 | $134,620 | $3,445 | 2.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 20 | 20 | $56,400 | $3,263 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 34 | $15,810 | $3,095 | 19.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 17 | $47,940 | $2,914 | 6.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $62,790 | $2,221 | 3.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 29 | $9,077 | $1,912 | 21.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 23 | 23 | $6,325 | $1,184 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 16 | 16 | $7,360 | $1,108 | 15.0% |
About Dr. Jimmy Kim, M.D
Dr. Jimmy Kim, M.D is a Gastroenterology healthcare provider based in Cudahy, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861587263.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jimmy Kim, M.D has received a total of $45.51 in payments from pharmaceutical and medical device companies, with $23.41 received in 2024. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($45.51).
As a Medicare-enrolled provider, Kim has provided services to 2,685 Medicare beneficiaries, totaling 3,187 services with total Medicare billing of $228,168. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Cudahy, WI
- Active Since 10/03/2006
- Last Updated 10/31/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1861587263
Products in Payments
- OCALIVA (Drug) $23.41
- LO LOESTRIN FE (Drug) $22.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.